Valink Therapeutics
YC W21 ↗Boston, US · Founded 2021 · 15 employees · 8 known investors
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
AI & Machine LearningBiotechHealthtechMedical DevicesTherapeuticsDrug discoveryin /71180674/@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (W21)
AS
Arne ScheuinFounder
IK
Irsyad KhairilinFounder
Investors · 8
In the news
- Valink Therapeutics: $11.8 Million Pre-A Funding Secured To Advance Next-Generation Oncology Pipelinepulse2.com · 2025
- Valink Therapeutics Raises $11.8 Million to Advance Bispecific ADC Platform for Cancer Treatmenttrial.medpath.com · 2025
- Valink Therapeutics raises £8.8m from Redalpine and LongeVC | Startupmagstartupmag.co.uk · 2025
- Medpathtrial.medpath.com · 2025
- Valink Therapeutics Closes $11.8M Pre-A Financing Roundfinsmes.com · 2025
